Alnylam Pharmace. buy Citigroup Inc.
Start price
25.06.24
/
50%
€225.00
Target price
25.06.25
€271.50
Performance (%)
23.51%
End price
26.06.25
€277.90
Summary
This prediction ended on 26.06.25 with a price of €277.90. The BUY prediction by Citigroup_Inc_ finished with a performance of 23.51%. Citigroup_Inc_ has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Citigroup_Inc_ has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 6.515% | 6.515% | -9.661% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at Citigroup Inc. from $227.00 to $291.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€384.10
02.09.25
02.09.25
€498.17
02.09.26
02.09.26
-34.03%
09:30
09:30
Stopped prediction by Citigroup_Inc_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€269.40
11.07.25
11.07.25
€346.03
11.07.26
11.07.26
-2.93%
12.07.26
12.07.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€261.50
21.03.25
21.03.25
€323.45
21.03.26
21.03.26
2.98%
22.03.26
22.03.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€247.40
02.08.24
02.08.24
€313.41
02.08.25
02.08.25
38.64%
03.08.25
03.08.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€136.40
16.02.24
16.02.24
€210.72
16.02.25
16.02.25
80.65%
17.02.25
17.02.25